RecruitingPhase 1NCT07315113
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Sponsor: Nuvectis Pharma, Inc.
Calverton, MD · +5 more sites
1 recruiting lung cancer studies with a site in Calverton, MD.
Sponsor: Nuvectis Pharma, Inc.
Calverton, MD · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.